• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小分子激活变构适体调控 sgRNA 实现 CRISPR-Cas9 的控制。

Control of CRISPR-Cas9 with small molecule-activated allosteric aptamer regulating sgRNAs.

机构信息

MOE Key Laboratory of Spectrochemical Analysis & Instrumentation, Collaborative Innovation Center of Chemistry for Energy Materials, Key Laboratory for Chemical Biology of Fujian Province, State Key Laboratory of Physical Chemistry of Solid Surfaces, College of Chemistry and Chemical Engineering, Xiamen University, Xiamen 361005, China.

Institute of Molecular Medicine, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200127, China.

出版信息

Chem Commun (Camb). 2019 Oct 8;55(81):12223-12226. doi: 10.1039/c9cc05531b.

DOI:10.1039/c9cc05531b
PMID:31552919
Abstract

The CRISPR-Cas9 system enables facile and efficient genome engineering in living cells and organisms. Small molecule control of CRISPR-Cas9 would allow precise temporal control in applications of the technology. In this work, we developed s[combining low line]mall m[combining low line]olecule-activated allosteric a[combining low line]ptamer r[combining low line]egulat[combining low line]ing (SMART)-sgRNAs as general strategies to control programmable genome editing. With SMART-sgRNAs, temporal control of the CRISPR-Cas9 system against different targets can be achieved, which should facilitate its application in various fields, such as biomedical genome editing, drug screening and chromosome imaging.

摘要

CRISPR-Cas9 系统使在活细胞和生物体中进行基因组工程变得容易和高效。小分子控制 CRISPR-Cas9 将允许在该技术的应用中进行精确的时间控制。在这项工作中,我们开发了小分子激活的变构适体调节(SMART)-sgRNA 作为控制可编程基因组编辑的通用策略。通过 SMART-sgRNA,可以实现针对不同靶标的 CRISPR-Cas9 系统的时间控制,这将有助于其在生物医学基因组编辑、药物筛选和染色体成像等各个领域的应用。

相似文献

1
Control of CRISPR-Cas9 with small molecule-activated allosteric aptamer regulating sgRNAs.小分子激活变构适体调控 sgRNA 实现 CRISPR-Cas9 的控制。
Chem Commun (Camb). 2019 Oct 8;55(81):12223-12226. doi: 10.1039/c9cc05531b.
2
Development of aptamer-based inhibitors for CRISPR/Cas system.基于适体的 CRISPR/Cas 系统抑制剂的开发。
Nucleic Acids Res. 2021 Feb 22;49(3):1330-1344. doi: 10.1093/nar/gkaa865.
3
Anti-CRISPR AcrIIA5 Potently Inhibits All Cas9 Homologs Used for Genome Editing.抗 CRISPR AcrIIA5 强烈抑制用于基因组编辑的所有 Cas9 同源物。
Cell Rep. 2019 Nov 12;29(7):1739-1746.e5. doi: 10.1016/j.celrep.2019.10.017.
4
Rapid Control of Genome Editing in Human Cells by Chemical-Inducible CRISPR-Cas Systems.通过化学诱导型CRISPR-Cas系统对人类细胞中的基因组编辑进行快速控制
Methods Mol Biol. 2018;1772:267-288. doi: 10.1007/978-1-4939-7795-6_15.
5
Development of a CRISPR/Cas9 genome editing toolbox for Corynebacterium glutamicum.开发用于谷氨酸棒杆菌的 CRISPR/Cas9 基因组编辑工具包。
Microb Cell Fact. 2017 Nov 16;16(1):205. doi: 10.1186/s12934-017-0815-5.
6
Co-delivery of Sorafenib and CRISPR/Cas9 Based on Targeted Core-Shell Hollow Mesoporous Organosilica Nanoparticles for Synergistic HCC Therapy.基于靶向核壳结构中空介孔有机硅纳米粒子的索拉非尼和 CRISPR/Cas9 共递送用于协同 HCC 治疗。
ACS Appl Mater Interfaces. 2020 Dec 23;12(51):57362-57372. doi: 10.1021/acsami.0c17660. Epub 2020 Dec 10.
7
CRISPR/Cas9 Platforms for Genome Editing in Plants: Developments and Applications.CRISPR/Cas9 平台在植物基因组编辑中的发展与应用。
Mol Plant. 2016 Jul 6;9(7):961-74. doi: 10.1016/j.molp.2016.04.009. Epub 2016 Apr 20.
8
The Smart Programmable CRISPR Technology: A Next Generation Genome Editing Tool for Investigators.智能可编程 CRISPR 技术:研究人员的下一代基因组编辑工具。
Curr Drug Targets. 2017;18(14):1653-1663. doi: 10.2174/1389450117666160527142321.
9
[Manipulating Living Systems by Light].《用光操控生命系统》
Yakugaku Zasshi. 2020;140(8):993-1000. doi: 10.1248/yakushi.20-00012-5.
10
[CRISPR/Cas9 and gene therapy].[CRISPR/Cas9与基因治疗]
Medicina (B Aires). 2017;77(5):405-409.

引用本文的文献

1
Conditional guide RNA deactivation by mRNA and small molecule triggers in Saccharomyces cerevisiae.酿酒酵母中通过mRNA和小分子触发实现条件性向导RNA失活
N Biotechnol. 2025 Jul 17;89:105-118. doi: 10.1016/j.nbt.2025.07.004.
2
Enhancing RNA editing efficiency and specificity with engineered ADAR2 guide RNAs.利用工程化ADAR2引导RNA提高RNA编辑效率和特异性。
Mol Ther Nucleic Acids. 2025 Jan 13;36(1):102447. doi: 10.1016/j.omtn.2025.102447. eCollection 2025 Mar 11.
3
Molecular Marvels: Small Molecules Paving the Way for Enhanced Gene Therapy.
分子奇迹:小分子为增强基因治疗铺平道路。
Pharmaceuticals (Basel). 2023 Dec 27;17(1):41. doi: 10.3390/ph17010041.
4
MiRNA-Responsive CRISPR-Cas System via a DNA Regulator.miRNA 响应型 CRISPR-Cas 系统通过 DNA 调节剂。
Biosensors (Basel). 2023 Nov 7;13(11):975. doi: 10.3390/bios13110975.
5
Real-time label-free detection of dynamic aptamer-small molecule interactions using a nanopore nucleic acid conformational sensor.利用纳米孔核酸构象传感器实时无标记检测动态适体-小分子相互作用。
Proc Natl Acad Sci U S A. 2023 Jun 13;120(24):e2108118120. doi: 10.1073/pnas.2108118120. Epub 2023 Jun 5.
6
Fluorescence Signal-Readout of CRISPR/Cas Biosensors for Nucleic Acid Detection.荧光信号读出的 CRISPR/Cas 生物传感器用于核酸检测。
Biosensors (Basel). 2022 Sep 20;12(10):779. doi: 10.3390/bios12100779.
7
Small Molecules for Enhancing the Precision and Safety of Genome Editing.小分子增强基因组编辑的精确性和安全性
Molecules. 2022 Sep 23;27(19):6266. doi: 10.3390/molecules27196266.
8
Riboswitches for Controlled Expression of Therapeutic Transgenes Delivered by Adeno-Associated Viral Vectors.用于腺相关病毒载体递送的治疗性转基因可控表达的核糖开关
Pharmaceuticals (Basel). 2021 Jun 10;14(6):554. doi: 10.3390/ph14060554.
9
Controlling CRISPR with small molecule regulation for somatic cell genome editing.利用小分子调控控制 CRISPR 进行体细胞基因组编辑。
Mol Ther. 2022 Jan 5;30(1):17-31. doi: 10.1016/j.ymthe.2021.06.014. Epub 2021 Jun 24.
10
Regulating CRISPR/Cas9 Function through Conditional Guide RNA Control.通过条件性向导 RNA 控制来调节 CRISPR/Cas9 功能。
Chembiochem. 2021 Jan 5;22(1):63-72. doi: 10.1002/cbic.202000423. Epub 2020 Nov 17.